curriculum vitae - University Institute of Immunology - UniversitÃ¤t Bern

More documents

Recommendations

Info

C.V.: Beda M. Stadler page 44A-187.A-188.A-189.A-190.A-191.A-192.A-193.A-194.A-195.A-196.A-197.A-198.A-199.A-200.A-201.A-202.A-203.A-204.A-205.A-206.A-207.A-208.Zürcher, A.W., Rudolf. M.P., Vogel. M., Stadler, B.M. Use of mimotpes for immunization and tolerization. IX.Meeting of the Swiss Immunology Ph.D. Students, Wolfsberg 1997.Horn, M.P., Krebs, S., Derer, T., Vogel, M., Miescher, S., Stadler,B.M. Appearance of cross-reactiveantibodies against the FcRI- chain after tetanus toxoid vaccination. IX. Meeting of the SwissImmunology Ph.D. Students, Wolfsberg 1997.Zimmermann, R., Finger, A., Hohenfeld, U., Klima,I., Gautschi, E., Thalmann, G.,Cecchini, M.G., Stadler,B.,Studer, U., Miescher, S., Ball, R. Gene therapy of prostate carcinoma by targeting tumour blood vessels. IX.Meeting of the Swiss Immunology Ph.D. Students, Wolfsberg 1997.Horn, M.P., Krebs, S., Derer, T., Vogel. M., Miescher, S., Stadler,B.M. Appearance of cross-reactiveantibodies against the FcRI- chain after tetanus toxoid vaccination. 13 th European Immunology Meeting,Amsterdam, 1997.Zürcher, M.P., Vogel. M., Zürcher, A.W., Rudolf, M.P., Kaufmann, H., Lang, A.B., Miescher, S.M., Stadler,B.M. Protective tetanus toxoid epitopes. 13 th European Immunology Meeting, Amsterdam, 1997.Kricek, F., Ruf, C., Rudolf, M.P., Stadler, B.M., Effenberger, F. and Reuschel, R. IgE-related peptidemimotopes: Basic structures for anti-allergy vaccine developement. 13 th European Immunology Meeting,Amsterdam, 1997.Kricek, F., Ruf, C., Nechanski, A., Pursch, E., Rudolf, M.P., and Stadler, B.M. Is IgE-FceRI binding andinduction of target cell triggering a process involving different Fce domains and conformationalrearrangement? 13 th European Immunology Meeting, Amsterdam, 1997.Pachlopnik, J.M., Stämpfli, M., Äbischer, I., Rudolf, M.P., Miescher, S., and Stadler, B.M. Different IgEconformations and IgE measurements. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 87. 1997.Thalmann, G., Ball, R. Stadler, B.M. and Studer U.E. Gentherapie der Neurovaskularistion von Tumoren.Schweiz. Ges. für Urologie, Jahresversammlung. Luzern, 1997Horn, M., Gerster, T., Vogel, M., Miescher, S., Kricek, F., Kinet, J-P., and Stadler, B.M. Autoantibodiesagainst both native and denatured FcRI--chain in human serum. SGAI Kongress 1998,Jahresversammlung Genf, 1998.Zürcher, A.W., Vogel, M., Rudolf, M.P., Kricek, F., and Stadler, B.M. Oral immunization with bacteriophages.SGAI Kongress 1998, Jahresversammlung Genf, 1998.Zürcher, A.P., Vogel, M., Zürcher,A.W., Kaufmann, H., Lang, A.B., Miescher, S.M., and Stadler, B.M.Protective tetanus toxoid epitopes. SGAI Kongress 1998, Jahresversammlung Genf, 1998.Vogel., M., Miescher, S.M., Rudolf, M.P., Kricek, F., and Stadler, B.M. Epitope mimicry by anti-idiotypicantibodies. SGAI Kongress 1998, Jahresversammlung Genf, 1998.Blumenthal, N.K., Vogel, M., Gerritsen H, Miescher, S.M., Furlan, M., Stadler, B.M. Autoantibodies as acausative agent of TTP? SGAI Kongress 1998, Jahresversammlung Genf, 1998.Cecchini M.G., Wetterwald A., Gautschi E., Stadler B.M., Studer U.E. and G.N. Thalmann: Isolation ofbacteriophage-displayed peptides that bind to human renal carcinoma endothelial cells ex vivo. ThirteenthCongress of the European Society for Urological Oncology and Endocrinology, Innsbruck, Austria,1998.Stadler, B.M. Mehr Allergien durch Gentechnik? Strategien zur Risikominimierung. 2. ISEM Jahrestagung1998, Giessen, Umweltmedizin in Forschung und Praxis . 3: 195. 1998.Escher, R., Wie, Y., Amstutz, P., Miescher, S.M., Vogel, M., Stadler, B.M., Berchtold P. Recombinant antigpIIB/IIIAautoantibodies from different normal donors share high homologies. American Society ofHematology Meeting, Miami Beach, Florida. 1998Vogel, M., Miescher, S., Kuhn, S., Stadler B.M. Un anticorps recombinant anti-idiotypique mimotope de l’IgE.Congrès sur les banques d’expression à la surface des phage, Les Pensières, Veyrier du Lac, 1998.Pachlopnik JM, Stämpfli MR, Aebischer I, Rudolf MP, Miescher SM, Stadler BM. Antigen interaction and heatinactivation expose new epitopes on human IgE. Tag der klinischen Forschung, Bern 1998Pachlopnik JM, Horn MP, Vogel M., Miescher SM, and. Stadler BM. Anti-FcRI antibodies used for isolationof anti-idiotypic Fabs and mimotopes in order to produce tools for active immunization. X. Meeting of theswiss immunology PH.D. students at Schloss Wolfsberg, 1998Finger, A.N., Wetterwald, A., Gautschi, E., Hohenfled, U., Thalmann, G.N., Miescher, S., Stadler, B.M.,Cecchini, M.G. Identification of bone marrow specific peptide ligands by phage petide library panning in vivo.Tag der Klinischen Forschung, Bern, 5.11.1998.Vogel, M., Miescher, S., Kuhn, S., Stadler B.M. Anti-Id vaccine to induce an anti-IgE response. PhageDisplay Technology Conference, Cardiff, 1998.
C.V.: Beda M. Stadler page 45A-209.A-210.A-211.A-212.A-213.A-214.A-215.Cecchini, M.G., Wetterwald, A., Thalmann, G., Finger, A.N., Gautschi, E., Hohenfeld, U., Bisoffi, M.,Miescher, S. Stadler, B.M. Identification of organ specific and tumor specific endothelial molecules by phagepeptide library panning in vivo and ex vivo. Tag der Klinischen Forschung, Bern, 5.11.1998.Miescher, S., Vogel, M., Kuhn, S., Stadler B.M., Fisch, I. Utilisation de globules rouges traitées à la bromélainpour isoler des anticorps recombinants anti-Rhésus D montrant une spécificité pour l’épitope rhésus DVI.Congrès sur les banques d’expression à la surface des phage, Les Pensières, Veyrier du Lac, 1998.Cecchini, M.G., Gautschi, E., Wetterwald,A., Thalmann, G.N., Miescher, S., Vogel, M. Stadler, B.M. Randompeptide phage displayed library panning in vivo: A method for the identification of bone marrow specificligands. Tag der Klinischen Forschung, Bern, 5.11.1998.Finger, A.N., Wetterwald, A., Gautschi, E., Hohenfeld, U., Thalmann, G.N., Miescher, S., Stadler, B.M.,Cecchini, M.G. Identification of bone marrow endothelial specific molecules by phage peptide library panningin vivo. Meeting of the swiss immunology PH.D. students at Schloss Wolfsberg, 1998.Cecchini, M.G., Wetterwald, A., Gautschi, E., Stadler, B.M., Studer, U.E., Thalmann, G.N. Isolation of phagedisplayedpeptides that bind to human renal carcinoma endothelial cells ex vivo. Tag der KlinischenForschung, Bern, 5.11.1998.Pachlopnik, J.M., Horn, M.P., Miescher, S.M., Stadler, B.M. Epitope specificity of anti- FcRI-antibodiesdetermines the autoimmune nature of chronic urticaria. SGAI Kongress 1999, InterlakenVogel, M. Kuhn, S., Miescher, S.M., Stadler, B.M. Anti-Id vaccine to induce an anti-IgE response. SGAIKongress 1999, InterlakenA-216.A-217.A-218.Horn, M.P., Vogel, M., Stadler, B.M., Miescher, S.M. Natural anti-FcR1 antibodies may serve as parentalantibodies for an anti-tetanus toxoid response. SGAI Kongress 1999, InterlakenFinger, A.N., A. Wetterwald, E. Gautschi, U. Hohenfeld, M. Bisoffi, G.N. Thalmann, S. Miescher, B.M. Stadlerand M.G. Cecchini (Bern): Identification of bone marrow specific ligands by phage peptide library panning invivo. SGAI Kongress 1999, InterlakenZuercher, A.W., S.M. Miescher, M. Vogel, M.P. Rudolf, M.B. Stadler and B.M. Stadler Oral anti-IgEimmunization with epitope-displaying phage: Evidence for transient colonization.. SGAI Kongress 1999,InterlakenA-219. Stadler, M.B., M.P. Horn, M. Vogel, M.P. Zürcher, A.W. Zürcher, A.B. Lang, S.M. Miescher and B.M. Stadler :Diphtheria toxin epitopes for synthetic vaccine. SGAI Kongress 1999, InterlakenA-220.A-221.A-222.A-223.A-224.A-225.A-226.A-227.A-228.A-229.Cecchini MG, Gautschi E, Wetterwald A, Finger AN, Hohenfeld U, Bisoffi M, Thalmann GN, Gimmi C, andStadler BM. Structural requirements of synthetic bone marrow targeting peptides (BMTPs) for binding to themarrow endothelium. NFP37 “Somatic Gene Therapy” Third Annual Meeting, Fribourg, October 7-8,1999.Cecchini MG, Gautschi E, Wetterwald A, Finger AN, Hohenfeld U, Bisoffi M, Thalmann GN, Gimmi C andStadler BM. Phage library panning in vivo as a method for the identification of ligands specific for the tumorvasculature. NFP37 “Somatic Gene Therapy” Third Annual Meeting, Fribourg, October 7-8, 1999.Pachlopnik JM, Horn MP, Miescher SM, and Stadler BM. Auto-antibody specificity and the pathogenesis ofautoimmune urticaria. XI. Meeting of the swiss immunology PH.D. students at Schloss Wolfsberg, 1999Christine Thurnheer, Adrian W. Zuercher, Sylvia M. Miescher, Michael P. Rudolf, Monique Vogel, and BedaM. Stadler. A Specificity for IgE-ND. SGAI Kongress 1999, InterlakenZürcher, M.P., M. Vogel, A.W. Zürcher, A.B. Lang, S.M. Miescher and B.M. Stadler . Tetanus VaccineGeneration via Antibody Selection in vitro SGAI Kongress 1999, InterlakenHorn, M.P., M. Vogel, B.M. Stadler, and S.M. Miescher. Are natural anti-FceRIa autoantibodies the parentalantibodies for TT specificity?. XI. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg. 1999Horn, M.P., M. Vogel, B.M. Stadler, and S.M. Miescher. Molecular characterization of natural anti-FcRIautoantibodies using phage display. Cambridge Healthtech Institute’s drug discovery & developement series.Phage display: Novel therapeutics and diagnostics. Cambridge, MA. USA 1999Zürcher, M.P., M. Vogel, A.W. Zürcher, A.B. Lang, S.M. Miescher and B.M. Stadler TETANUS VACCINEGENERATION VIA ANTIBODY SELECTION Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1999Stadler, M.B., Horn, M.P., Vogel M., Zürcher M.P., Zürcher A.W., Lang A.B., Miescher S.M. and Stadler B.M.DIPHTHERIA TOXIN: IS THE MOST PROTECTIVE EPITOPE MIMICKING SELF? Meeting of the SwissImmunology Ph.D. Students. Wolfsberg. 1999Finger, A.N., Wetterwald, A., Gautschi, E., Hohenfeld, U., Bisoffi, M., Thalmann, G.N., Miescher, S., Stadler,B.M. Cecchini, M.G. Identification of bone marrow specific peptide ligands by random peptide phagedisplayed library panning in vivo. Keystone Symposia, January, 14 - January, 20, 1999.
Page 1 and 2: CURRICULUM VITAENameBeda Martin STA
Page 3 and 4: C.V.: Beda M. Stadler page 3EDUCATI
Page 5 and 6: C.V.: Beda M. Stadler page 5Special
Page 7 and 8: C.V.: Beda M. Stadler page 7Societi
Page 9 and 10: C.V.: Beda M. Stadler page 92001 -
Page 11 and 12: C.V.: Beda M. Stadler page 11Editor
Page 13 and 14: C.V.: Beda M. Stadler page 1316. Lu
Page 15: C.V.: Beda M. Stadler page 1553. Br
Page 18 and 19: C.V.: Beda M. Stadler page 18104. S
Page 20 and 21: C.V.: Beda M. Stadler page 20Monogr
Page 22 and 23: C.V.: Beda M. Stadler page 22R-32.R
Page 28 and 29: C.V.: Beda M. Stadler page 28Patent
Page 30 and 31: C.V.: Beda M. Stadler page 30Editor
Page 32 and 33: C.V.: Beda M. Stadler page 32I-40.I
Page 34 and 35: C.V.: Beda M. Stadler page 34I-80.B
Page 36: C.V.: Beda M. Stadler page 36Abstra
Page 39 and 40: C.V.: Beda M. Stadler page 39A-71.A
Page 41 and 42: C.V.: Beda M. Stadler page 41A-115.
Page 43: C.V.: Beda M. Stadler page 43A-165.
Page 47 and 48: C.V.: Beda M. Stadler page 47A-250.

curriculum vitae - University Institute of Immunology - UniversitÃ¤t Bern

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?